Fluorescent Zn
2+
sensors play a pivotal role in zinc
biology, but their application in complex media such as blood serum
or plate reader-based cellular assays is hampered by autofluorescence
and light scattering. Bioluminescent sensor proteins provide an attractive
alternative to fluorescent sensors for these applications, but the
only bioluminescent sensor protein developed so far, BLZinCh, has
a limited sensor response and a suboptimal Zn
2+
affinity.
In this work, we expanded the toolbox of bioluminescent Zn
2+
sensors by developing two new sensor families that show a large
change in the emission ratio and cover a range of physiologically
relevant Zn
2+
affinities. The LuZi platform relies on competitive
complementation of split NanoLuc luciferase and displays a robust,
2-fold change in red-to-blue emission, allowing quantification of
free Zn
2+
between 2 pM and 1 nM. The second platform was
developed by replacing the long flexible GGS linker in the original
BLZinCh sensor by rigid polyproline linkers, yielding a series of
BLZinCh-Pro sensors with a 3–4-fold improved ratiometric response
and physiologically relevant Zn
2+
affinities between 0.5
and 1 nM. Both the LuZi and BLZinCh-Pro sensors allowed the direct
determination of low nM concentrations of free Zn
2+
in
serum, providing an attractive alternative to more laborious and/or
indirect approaches to measure serum zinc levels. Furthermore, the
genetic encoding of the BLZinCh-Pro sensors allowed their use as intracellular
sensors, where the sensor occupancy of 40–50% makes them ideally
suited to monitor both increases and decreases in intracellular free
Zn
2+
concentration in simple, plate reader-based measurements,
without the need for fluorescence microscopy.